Integral Molecular Opens New Research Center in Philadelphia

medical news© Jae Young Ju / Getty Images / Canva

PHILADELPHIA, PA — Integral Molecular, a founding member of Philadelphia’s biotech community, announced the official opening Friday of its 32,000-square-foot headquarters and integrated research facilities that will include its pandemic preparedness laboratories. Integral Molecular is the first tenant to move into One uCity, a 13-story, 400,000-square-foot commercial research building that will celebrate its opening later this year

Integral Molecular has been at the forefront of Pennsylvania’s response to the COVID-19 pandemic, and the company’s technologies for studying viruses have contributed to its extraordinary growth since 2020. When fully occupied, the company’s new site will accommodate 200 employees and add 100 new technology-based jobs to the region. This growth doubles the footprint of Integral Molecular’s headquarters and comes just a few years after its last expansion in 2019, which saw the opening of a second research facility.

“Our expansion in uCity Square marks a new and exciting time for Integral Molecular,” said Ben Doranz, co-founder and CEO of Integral Molecular. “Throughout the pandemic we have provided safe ‘pseudovirus’ particles as a critical reagent to vaccine developers seeking alternatives to ‘live’ virus. With our expanded infrastructure, we have more capacity for R&D and manufacturing and can quickly mobilize our technologies to combat future viral threats.”

Integral Molecular inaugurated its new site yesterday in an event attended by Philadelphia Mayor Jim Kenney and local leaders. The company’s new laboratories at One uCity are now fully operational, and planning is underway for a second phase of expansion.

“Integral Molecular is a long-time leader of Philadelphia’s biotech community and we are thrilled to see the company expand in our booming life sciences hub,” said Philadelphia Mayor Jim Kenney. “Philadelphia is the birthplace of cell and gene therapy. Currently, there are billions of dollars of life science projects in various stages of planning and development in Philadelphia, setting the stage for tremendous growth in jobs and scientific advances. Integral Molecular continues to produce innovative research solutions and help companies around the world advance therapeutics while expanding skills-based job training opportunities for Philadelphians of all ages.”

READ:  RaicesCon 2023 Announces Change of Venue to Accommodate Overwhelming Early Demand

“Integral Molecular has been at the forefront of Philadelphia’s burgeoning life sciences community for over two decades and embodies all that our ecosystem has to offer in terms of talent, research, and collaboration,” said Pete Cramer, Vice President, Development at Wexford Science & Technology. “We are thrilled to support and celebrate Integral’s continued growth and expansion at uCity Square.” One uCity is the newest addition to the uCity Square innovation community being developed by Wexford Science & Technology, Ventas, Inc. (NYSE: VTR), and the University City Science Center.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.